Annovis is also seeking fresh capital while working to advance trials for both Alzheimer's and Parkinson's disease drugs.

Abbott to lead the sustainable agriculture company through global growth as it transforms agriculture with its patented crop nutrition innovations and upends the $190B nitrogen market 1 Company ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Most of Kelderman's pay was in ...

Henry Gosebruch, who has $3.5 billion in capital to deploy, is thinking broad as he steers the decades-old biotech out of ...

John Crowley, the longtime leader of rare disease drug developer Amicus Therapeutics and a board member of the Biotechnology Innovation Organization, will become the trade organization’s new president ...

Conversion of promissory notes into common stock removed $94.9 million in pro forma balance sheet liabilities. The converted common stock is included in the company’s total 165 million outstanding ...

MINNEAPOLIS, Oct. 22, 2025 /PRNewswire/ -- Pivot Bio, one of the world's leading innovative agtech companies, is taking center stage this week at the Norman E. Borlaug International Dialogue, part of ...

Rachel King is a trailblazer in biotech, a venture capitalist turned co-founder and CEO, now turned industry leader. As CEO of the Biotechnology Innovation Organization (BIO), King has focused in ...

Kronos Bio (NASDAQ:KRON) announced Wednesday its CFO Deborah Knobelman will become the company’s interim Chief Executive Officer on Dec. 3, replacing Norbert Bischofberger, who will resign as ...